AAV vector refers to adeno-associated virus vector. It is commonly used in gene therapy. AAV vectors can deliver genetic material into cells. They are known for their safety and efficiency. These vectors have applications in treating genetic disorders. Researchers utilise AAV vectors for various medical advancements. Their role is significant in modern biotechnology and therapeutic development.
On 23 April 2026, the United States Food and Drug Administration approved Otarmeni (lunsotogene parvec-cwha), the first dual adeno-associated virus vector-based gene therapy for inherited hearing loss. The...
